NYC startup
from24/7 Wall St.
1 week agouniQure, Syndax and Erasca Are Drawing Analyst Interest Ahead of Key Drug Catalysts
Wall Street upgraded three clinical-stage biotechs with binary catalysts where market pricing underestimates approval probability: uniQure, Syndax, and Erasca.